Aytu BioPharma (NASDAQ: AYTU) is a specialty pharmaceutical company with a growing commercial portfolio of prescription therapeutics and consumer health products, including ADHD and pediatrics medications. Their evolution has been driven by strategic in-licensing, acquisition-based transactions and organic product growth. As they continue on this trajectory, they are building a complimentary therapeutic development pipeline that will address significant unmet needs.

Pharmaceutical

Aytu BioScience

Josh Disbrow

Victoria Cordova

Ryan Selhorn

Russ McMahen

Greg Pyszczymuka

Margaret Cabano

Suzane Kennedy

Jarrett Disbrow

Management and Strategy

Sales And Marketing Team

Finance and Accounting

Leadership Team

Commercial Insights and Analytics Team

Research and Development Team

Teams at Aytu BioScience